Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis

Woon-Ki Kim, Jin-Chun Kim, Hyun-Jung Park, Ok‐Joo Sul, Mi‐Hyun Lee, Ji-Soon Kim, Hye‐Seon Choi

Experimental & Molecular Medicine · 2012 · 34 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

Platinum nanoparticles (PtNP) exhibit remarkable antioxidant activity. There is growing evidence concerning a positive relationship between oxidative stress and bone loss, suggesting that PtNP could protect against bone loss by modulating oxidative stress. Intragastric administration of PtNP reduced ovariectomy (OVX)- induced bone loss with a decreased level of activity and number of osteoclast (OC) in vivo. PtNP inhibited OC formation by impairing the receptor activator of nuclear factor-κB ligand (RANKL) signaling. This impairment was due to a decreased activation of nuclear factor-κB and a reduced level of nuclear factor in activated T-cells, cytoplasmic 1 (NFAT2). PtNP lowered RANKL-induced long lasting reactive oxygen species as well as intracellular concentrations of Ca(2+) oscillation. Our data clearly highlight the potential of PtNP for the amelioration of bone loss after estrogen deficiency by attenuated OC formation.

References

26